DK3052109T3 - Terapi med celler fra human placenta og hematopoietiske celler - Google Patents
Terapi med celler fra human placenta og hematopoietiske celler Download PDFInfo
- Publication number
- DK3052109T3 DK3052109T3 DK14850630.6T DK14850630T DK3052109T3 DK 3052109 T3 DK3052109 T3 DK 3052109T3 DK 14850630 T DK14850630 T DK 14850630T DK 3052109 T3 DK3052109 T3 DK 3052109T3
- Authority
- DK
- Denmark
- Prior art keywords
- cells
- therapy
- human placenta
- hematopoietic
- hematopoietic cells
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Pregnancy & Childbirth (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Transplantation (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361886648P | 2013-10-03 | 2013-10-03 | |
US201361890057P | 2013-10-11 | 2013-10-11 | |
PCT/US2014/058774 WO2015051088A1 (en) | 2013-10-03 | 2014-10-02 | Therapy with cells from human placenta and hematopoietic cells |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3052109T3 true DK3052109T3 (da) | 2021-08-16 |
Family
ID=52779130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK14850630.6T DK3052109T3 (da) | 2013-10-03 | 2014-10-02 | Terapi med celler fra human placenta og hematopoietiske celler |
Country Status (12)
Country | Link |
---|---|
US (1) | US10179152B2 (da) |
EP (1) | EP3052109B8 (da) |
JP (4) | JP2016531889A (da) |
KR (3) | KR20160102965A (da) |
CN (1) | CN105792834A (da) |
AU (3) | AU2014329513A1 (da) |
CA (1) | CA2926199C (da) |
DK (1) | DK3052109T3 (da) |
MX (2) | MX2016004209A (da) |
RU (2) | RU2016116816A (da) |
WO (1) | WO2015051088A1 (da) |
ZA (1) | ZA201602151B (da) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10426796B2 (en) | 2016-06-13 | 2019-10-01 | SMART SURGICAL, Inc. | Compositions for biological systems and methods for preparing and using the same |
US10456423B2 (en) | 2016-06-13 | 2019-10-29 | SMART SURGICAL, Inc. | Compositions for biological systems and methods for preparing and using the same |
US11285177B2 (en) | 2018-01-03 | 2022-03-29 | Globus Medical, Inc. | Allografts containing viable cells and methods thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5437994A (en) * | 1989-06-15 | 1995-08-01 | Regents Of The University Of Michigan | Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells |
IL107483A0 (en) * | 1993-11-03 | 1994-02-27 | Yeda Res & Dev | Bone marrow transplantation |
EP2316919B1 (en) * | 2001-02-14 | 2015-10-07 | Anthrogenesis Corporation | Post-partum mammalian placenta, its use and placental stem cells therefrom |
NZ542127A (en) * | 2003-02-13 | 2008-04-30 | Anthrogenesis Corp | Use of umbilical cord blood to treat individuals having a disease, disorder or condition |
EP1976978A2 (en) * | 2005-12-29 | 2008-10-08 | Anthrogenesis Corporation | Co-culture of placental stem cells and stem cells from a second source |
US20110059050A1 (en) * | 2006-01-27 | 2011-03-10 | Kyle Cetrulo | Methods and compositions relating to stem cell transplantation |
CN101483998A (zh) * | 2006-05-11 | 2009-07-15 | 武部直子 | 收集和使用胎盘脐血干细胞的方法 |
KR20190132556A (ko) * | 2007-09-28 | 2019-11-27 | 안트로제네시스 코포레이션 | 인간 태반 관류액 및 인간 태반-유래 중간체 천연 킬러 세포를 사용한 종양 억제 방법 |
-
2014
- 2014-10-02 WO PCT/US2014/058774 patent/WO2015051088A1/en active Application Filing
- 2014-10-02 RU RU2016116816A patent/RU2016116816A/ru unknown
- 2014-10-02 US US15/026,896 patent/US10179152B2/en active Active
- 2014-10-02 EP EP14850630.6A patent/EP3052109B8/en active Active
- 2014-10-02 KR KR1020167011298A patent/KR20160102965A/ko not_active Application Discontinuation
- 2014-10-02 CN CN201480066174.6A patent/CN105792834A/zh active Pending
- 2014-10-02 CA CA2926199A patent/CA2926199C/en active Active
- 2014-10-02 KR KR1020217013395A patent/KR20210054046A/ko not_active Application Discontinuation
- 2014-10-02 RU RU2019131152A patent/RU2019131152A/ru unknown
- 2014-10-02 KR KR1020227010134A patent/KR20220044384A/ko not_active Application Discontinuation
- 2014-10-02 AU AU2014329513A patent/AU2014329513A1/en not_active Abandoned
- 2014-10-02 DK DK14850630.6T patent/DK3052109T3/da active
- 2014-10-02 JP JP2016519848A patent/JP2016531889A/ja active Pending
- 2014-10-02 MX MX2016004209A patent/MX2016004209A/es unknown
-
2016
- 2016-03-31 ZA ZA2016/02151A patent/ZA201602151B/en unknown
- 2016-04-01 MX MX2021003798A patent/MX2021003798A/es unknown
-
2019
- 2019-06-18 JP JP2019112450A patent/JP2019194211A/ja not_active Withdrawn
-
2020
- 2020-03-23 AU AU2020202076A patent/AU2020202076A1/en not_active Abandoned
-
2021
- 2021-04-07 JP JP2021065060A patent/JP2021107407A/ja not_active Withdrawn
-
2022
- 2022-08-10 AU AU2022215207A patent/AU2022215207A1/en not_active Abandoned
-
2023
- 2023-02-27 JP JP2023027978A patent/JP2023078156A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2014329513A1 (en) | 2016-04-28 |
AU2022215207A1 (en) | 2022-09-01 |
US20160235790A1 (en) | 2016-08-18 |
MX2016004209A (es) | 2016-07-11 |
JP2019194211A (ja) | 2019-11-07 |
CA2926199C (en) | 2022-05-17 |
EP3052109A4 (en) | 2017-05-03 |
RU2019131152A3 (da) | 2022-02-24 |
KR20160102965A (ko) | 2016-08-31 |
JP2021107407A (ja) | 2021-07-29 |
JP2023078156A (ja) | 2023-06-06 |
CA2926199A1 (en) | 2015-04-09 |
RU2019131152A (ru) | 2019-11-11 |
ZA201602151B (en) | 2022-12-21 |
NZ718571A (en) | 2023-12-22 |
EP3052109A1 (en) | 2016-08-10 |
JP2016531889A (ja) | 2016-10-13 |
RU2016116816A (ru) | 2017-11-13 |
MX2021003798A (es) | 2021-05-27 |
US10179152B2 (en) | 2019-01-15 |
RU2016116816A3 (da) | 2018-08-02 |
KR20220044384A (ko) | 2022-04-07 |
EP3052109B8 (en) | 2021-06-23 |
AU2020202076A1 (en) | 2020-04-09 |
CN105792834A (zh) | 2016-07-20 |
EP3052109B1 (en) | 2021-05-12 |
KR20210054046A (ko) | 2021-05-12 |
WO2015051088A1 (en) | 2015-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL262134B (en) | Human or large mammal lung bioreactor | |
IL244296A0 (en) | Cell-permeable conjugates and methods of using them | |
DK3462569T3 (da) | Batteri og ubemandet luftfartøj med batteri | |
BR112015030972A2 (pt) | células sc-beta e composições e métodos para geração das mesmas | |
DK3019483T3 (da) | Terapeutiske aktive forbindelser og fremgangsmåder til deres anvendelse | |
DK2920313T3 (da) | Rekombinante adenovira og anvendelse deraf | |
DK3083616T3 (da) | Bicykliske heterocykliske forbindelser og disses anvendelser i terapi | |
DK3027208T3 (da) | Cancerdiagnose og -terapi, der involverer cancerstamceller | |
DK2855736T3 (da) | Elektrolysator og energisystem | |
SG10202004535PA (en) | Enhanced adoptive cell therapy | |
DK3351239T3 (da) | Prostamid-indeholdende intraokulære implantater og fremgangsmåder til anvendelse deraf | |
DK3003117T3 (da) | Videolaryngoskop og laryngoskopindføringsdel | |
DK3065759T3 (da) | Immunosuppressive midler og deres anvendelse i terapi | |
DK3077467T3 (da) | Sikkativsammensætning og anvendelse deraf | |
DK3029038T3 (da) | Tetrazolinonforbindelse og anvendelse deraf | |
DK3326642T3 (da) | Langtidsvirkende koagulationsfaktorer og brugen deraf | |
DK3245873T3 (da) | Herbicid-kombination med pelargonsyre og flazasulfuron | |
DK2964767T3 (da) | Toksingener og fremgangsmåder til anvendelse deraf | |
DK3064491T3 (da) | Sulfonamidderivat og medicinsk anvendelse deraf | |
DK3049473T3 (da) | Dobbeltderivatiserede chitosannanopartikler og fremgangsmåder til fremstilling og anvendelse heraf til genoverførsel in vivo | |
IL245272B (en) | pif-transfected cells and methods of use | |
DK3057979T3 (da) | Proteiner med diagnostiske og terapeutiske anvendelser | |
DK3083944T3 (da) | Pattedyrsmuskelafledte stamceller | |
DK3074029T3 (da) | Antineuroinflammatoriske og beskyttende forbindelser i achillea fragrantissima | |
DK3033350T3 (da) | Progesterone fosfatanaloger og anvendelser relateret dertil |